News 17.07.18

Dutch Heart Foundation, UMC Groningen and Pivot Park Screening Centre collaborate on heart failure

Scientists from UMC Groningen and Pivot Park Screening Centre have started a study with the objective to prevent one of the causes of heart failure. It is the first time that a protein related to protection of the heart muscle from stiffening, will be screened to discover a starting point for development of a new medicine.

Read more
News 11.07.18

High number of SMEs benefit greatly from the European Lead Factory

The European Lead Factory is remarkably attractive for SMEs. The consortium consists of 30 partners, of which 10 are SMEs....

Read more
News 24.05.18

PPSC will take part in the 19th Annual Drug Discovery Summit in Berlin, June 7th/8th

Dr. Saman Honarnejad, project manager for COILED (Center for Open Innovation in LEad Discovery) program at Pivot Park Screening Centre (PPSC) will be chairman and one of the speakers of the “Drug Discovery Strategies and Innovation” session at the “19th Annual Drug Discovery Summit in Berlin” (Stream 1, day 1). 

Read more
News 05.04.18

COILED announces discovery of promising starting points to modulate trained immunity

COILED (Center for Open Innovation in LEad Discovery) announced today the first results of an ultra High Throughput Screening (uHTS) campaign on a prime epigenetic enzyme target that plays a key role in controlling trained immunity.

Read more
News 01.03.18

Brigitte Drees appointed as CEO Pivot Park and Pivot Park Screening Centre

As of March 1st, Brigitte Drees has been  appointed  as Pivot Park’s new CEO.  With her extensive experience in the...

Read more
News 20.09.17

BioAscent to Manage PPSC’s Library of over 300,000 Compounds

BioAscent Discovery Limited has announced an agreement with Pivot Park Screening Centre (PPSC, Oss, The Netherlands), under which it is managing PPSC’s entire screening collection of over 300,000 compounds.

Read more
News 12.09.17

Exciting new hits for a novel drug target involved in depression and pain unveiled in the European Lead Factory project

ioneering ideas to improve antidepressant therapies are greatly required since existing antidepressants are moderately effective and the response rate in patients suffering from depression is approximately less than 50%.

Read more
News 31.05.17

NCardia partners with Pivot Park Screening Centre to offer ultra High Throughput Screening for Cardiovascular drug discovery services

NCardia and Pivot Park Screening Centre announced a collaboration to improve NCardia's cardiovascular drug discovery service offerings and to expand Pivot Park Screening Centre’s knowledge about new and innovative assay technologies used to accelerate drug discoveries.

Read more
News 28.02.17

Committed to strengthening the antibiotic arsenal

The European Lead Factory (ELF) is boosting the discovery of new drugs by making high throughput screening and a quality compound library available to academia and biotech’s.

Read more
  • 1
  • 2